论文部分内容阅读
临床研究报告糖尿病患者动脉粥样硬化性疾病的发生显著高于一般人群，且起病年龄较早，部分原因可能与糖尿病常合并脂代谢紊乱和纤溶障碍等有关。１９９６年７月～１９９７年５月，我们应用双胍类药物（美迪康：药物成分为二甲双胍，深圳中联制药厂生产）对３２例新诊断的２型
Clinical studies report the incidence of atherosclerotic disease in diabetic patients was significantly higher than the general population, and the age of onset earlier, in part due to diabetes may be associated with dyslipidemia and fibrinolytic disorders. From July 1996 to May 1997, we applied biguanides (meticonazole: metformin, manufactured by Shenzhen Zhonglian Pharmaceutical Factory) to 32 newly diagnosed type 2